D-Wave Quantum (NYSE:QBTS) 주식

D-WAVE QUANTUM INC

D-Wave Quantum

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Xpeng, Hesai Group, Kohl's, Groupon, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Equities

News

Markets

QBTS

QUBT

TSLA

목요일(20일) 미국 증시는 하락세로 마감했다. 목요일 주목받은 주식: 나이키, 퀀텀 컴퓨팅, 페덱스, D-웨이브 퀀텀 및 테슬라

목요일 주목받은 주식: 나이키, 퀀텀 컴퓨팅, 페덱스, D-웨이브 퀀텀 및 테슬라

Nvidia, AMD, Archer Aviation, Rocket Lab, And Tesla: Why Are These 5 Stocks On Investors' Radars Today

NVDA

SRPT

화요일(18일) 미국 증시는 투자자들이 연준의 금리 결정을 기다리면서 하락했다. 화요일 주목받은 주식: 엔비디아, 메타, 사렙타, D-웨이브 및 테슬라

화요일 주목받은 주식: 엔비디아, 메타, 사렙타, D-웨이브 및 테슬라

Wooden,Cubes,With,Blue,Letters,Forming,The,Word,Etfs,(exchange

Sector ETFs

ETFs

AVGO

BABA

BIDU

NVDD

Direxion Daily Semiconductor Bear 3X Shares

SOXS

3월 18일 개막한 엔비디아(NASDAQ:NVDA) GPU 기술 컨퍼런스(GTC)는 인공지능(AI)과 반도체에 대한 또 다른 열기를 위한 토대를 마련했다. 과거 실적을 바탕으로 볼 때 이번 행사는 일부 ETF에 새로운 모멘텀을 가져다줄 수 있다.

작년 엔비디아 GTC 이후 높은 수익률 기록했던 반도체 ETF 3종목...이번에는 다를까?

D-Wave Quantum Inc

D-Wave Quantum Inc. Warrants, each whole warrant exercisable for 1.4541326 Common Shares at an exercise price of $11.50

Wells Fargo analyst Ken Gawrelski maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Overweight and lowers the price target from $215 to $158.

Price Target

Analyst Ratings

RDDT

Wells Fargo Maintains Overweight on Reddit, Lowers Price Target to $158

Earnings

Market Summary

Broad U.S. Equity ETFs

Events

Econ #s

Opinion

Trading Ideas

EBAY

TXRH

Market Momentum: Your Weekly Financial Forecast & Market Prep

Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Outperform and raises the price target from $142 to $150.

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $150

Vaxcyte Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) on Monday released topline results from its Phase 2 dose-finding study evaluating the safety, tolerability and immunogenicity of VAX-24, a 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD), compared to Pfizer Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) Prevnar 20&nbsp;(PCV20) <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">in healthy infants</a>.
The company has selected the VAX-24 Mid-dose as the basis for advancing an optimized dose formulation to a potential Phase 3 program.
Pending the VAX-31 infant Phase 2 study topline data results anticipated in mid-2026, it plans to initiate an infant Phase 3 study with <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44558031/vaxcyte-announces-positive-topline-results-from-vax-24-infant-phase-2-dose-finding-study" rel="noreferrer noopener">either VAX-24 or VAX-31</a>.
In this Phase 2 study, VAX-24 was well-tolerated and demonstrated a safety profile similar to PCV20 across all doses studied.
Frequently reported local and systemic reactions were generally mild to moderate, resolving within several days of vaccination, with no meaningful differences observed across the cohorts.
No serious adverse events were considered to be related to the study vaccines.
Post-dose 3, the VAX-24 Mid dose met target precedent Phase 2 non-inferiority (NI) criteria on relative seroconversion rates, particularly for the highest circulating serotypes2&nbsp;contained in VAX-24 and for 20 of 24 serotypes overall.
The Mid dose also met the target Phase 2 IgG Geometric Mean Ratio (GMR) point estimate of &gt;0.63&nbsp;on all currently circulating serotypes contained in VAX-24 and for 22 of 24 serotypes overall.
Post-dose 3, VAX-24 generated robust OPA responses, which are correlated with effectiveness against IPD across all serotypes and doses.
The four serotypes unique to VAX-24 elicited immune responses and met all target criteria across all endpoints at all doses evaluated post-dose 3 (primary immunization series).
Dose-dependent immune responses were consistently demonstrated at 1.1mcg, 2.2mcg, and 4.4mcg doses. Little to no carrier suppression was observed.
Full post-dose 4 booster data is expected by the end of 2025.
An interim assessment of the IgG results was performed with currently available study samples and demonstrated:
<ul>
<li>The Mid dose met the company&#8217;s historical target Phase 2 IgG GMR point estimate of &gt;0.6 for the highest circulating serotypes contained in VAX-24 and for 19 of 24 serotypes overall.</li>
<li>VAX-24 elicited memory responses across all doses for all serotypes.</li>
</ul>
Price Action: PCVX stock is down 29.5% at $48.99 during the premarket session at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44544677/regulatory-uncertainty-meets-power-surge-jp-morgans-take-on-talen-constellation-and-vistra-stocks" target="_blank" rel="noreferrer noopener">JP Morgan&#8217;s Stock Picks In The Power Sector Amid Regulatory Uncertainty</a></li>
</ul>
Photo: Shutterstock

Biotech

Large Cap

Health Care

Movers

General

PCVX

Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine

WIIM

LPLA

LPL Financial shares are trading lower after the company announced it entered into a definitive purchase agreement to acquire Commonwealth Financial Network for approximately $2.7 billion in cash.

Stifel Maintains Hold on Alphabet, Price Target From $184 To $167 &nbsp;

CORT

Corcept Therapeutics shares are trading higher after the company announced it met its primary endpoint for its Phase 3 ROSELLA trial of Relacorilant.

HC Wainwright &amp; Co. analyst Robert Burns reiterates ADC Therapeutics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NYSE">ADCT</a>) with a Buy and maintains $8 price target.

Reiteration

ADCT

HC Wainwright & Co. Reiterates Buy on ADC Therapeutics, Maintains $8 Price Target

Susquehanna analyst Bascome Majors maintains XPO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) with a Positive and lowers the price target from $180 to $138.

Susquehanna Maintains Positive on XPO, Lowers Price Target to $138

HC Wainwright &amp; Co. analyst Robert Burns reiterates Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) with a Buy and maintains $10 price target.

CATX

HC Wainwright & Co. Reiterates Buy on Perspective Therapeutics, Maintains $10 Price Target

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>BMO Capital analyst Katja Jancic downgraded the rating for United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) from Outperform to Market Perform and maintained the price target of $45. United States Steel shares closed at $43.00 on Friday. <a href="https://www.benzinga.com/quote/X/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst James West downgraded ChargePoint Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) from Outperform to In-Line and lowered the price target from $4 to $1. ChargePoint shares closed at $0.6185 on Friday. <a href="https://www.benzinga.com/quote/CHPT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Adrienne Yih downgraded Canada Goose Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) from Equal-Weight to Underweight and lowered the price target from $10 to $8. Canada Goose shares closed at $8.24 on Friday. <a href="https://www.benzinga.com/quote/GOOS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Daniel Major downgraded Agnico Eagle Mines Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>) from Buy to Neutral and raised the price target from $100 to $110. Agnico Eagle Mines shares closed at $107.36 on Friday. <a href="https://www.benzinga.com/quote/AEM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44554966/pvh-progress-software-and-3-stocks-to-watch-heading-into-monday">PVH, Progress Software And 3 Stocks To Watch Heading Into Monday</a></li>
</ul>

Downgrades

Pre-Market Outlook

CHPT

GOOS

This United States Steel Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday

The <a href="https://www.benzinga.com/topic/s-p-500">S&amp;P 500 had</a> a rough start to 2025, sinking 6.53% over the first quarter, but not every sector suffered the same fate. 
While energy stocks lit up the leaderboard with a scorching 9.31% gain, consumer discretionary and technology stocks took a beating, plunging 14.23% and 13.1%, respectively.
<h2 class="wp-block-heading">Energy's Power Play</h2>
Oil and gas stocks came out swinging, with Hess Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HES#NYSE">HES</a>) leading the charge, soaring 21.34% over the past three months. EQT Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) followed closely, rising 19.61%, while Devon Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) and Coterra Energy (CTRA) also <a href="https://www.sectorspdrs.com/sectortracker">posted</a> double-digit gains. 
The biggest energy players, Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) and Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), delivered solid performances as well, gaining 15.34% and 10.57%, respectively.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44512999/chevron-hits-52-week-high-warren-buffetts-5th-largest-holding-is-on-fire-but-should-you-buy">Chevron Hits 52-Week High – Warren Buffett&#8217;s 5th Largest Holding Is on Fire, But Should You Buy?</a>
<h2 class="wp-block-heading">Consumer Discretionary's Divide</h2>
It was a brutal quarter for consumer discretionary, but not all stocks in the sector were drowning. Auto parts retailers proved surprisingly resilient, with O'Reilly Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) accelerating 17.64% and AutoZone Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) climbing 16.33%. Yum! Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>), the parent company of Taco Bell and KFC, also managed a 15.18% gain, proving that fast food remains a winning bet even in choppy markets.
<h2 class="wp-block-heading">Tech's Tough Quarter—But Some Shined</h2>
Tech stocks had a miserable run, but a few managed to buck the trend. VeriSign Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>) surged 23.03%, leading the charge, while Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) and Roper Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) gained 11.87% and 11.21%, respectively. IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) also posted a solid 9.53% gain, and Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) continued its momentum, adding 8.56%.
<h2 class="wp-block-heading">What's Next?</h2>
With the second quarter underway, investors will be watching if Energy can keep its momentum or if beaten-down sectors like Tech and Consumer Discretionary stage a comeback. 
For now, it&#8217;s clear: Energy stocks ruled the first quarter, while Tech and Discretionary stocks got left in the dust.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44533263/top-3-information-technology-stocks-that-could-blast-off-this-month">Top 3 Information Technology Stocks That Could Blast Off This Month</a></li>
</ul>
Image: Shutterstock

Long Ideas

Tech

CTRA

INTC

ORLY

PLTR

VRSN

Chevron, Exxon, Hess Lead As Tech Giants Stumble In Q1 2025

Susquehanna analyst Bascome Majors maintains TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) with a Positive and lowers the price target from $135 to $105.

TFII

Susquehanna Maintains Positive on TFI International, Lowers Price Target to $105

IM Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.39) by 41.03 percent. This is a 78.7 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $9.54 million which missed the analyst consensus estimate of $10.43 million by 8.58 percent. This is a 21.28 percent increase over sales of $7.86 million the same period last year.

Earnings Beats

Earnings Misses

IMCC

IM Cannabis Q4 GAAP EPS $(0.23) Beats $(0.39) Estimate, Sales $9.54M Miss $10.43M Estimate

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

MSTR

Microstrategy Acquired 22,048 BTC For $1.92B During Period March 24 To March 30

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/03/28/final-trades-paypal-meta-abbvie-and-snowflake.html">Halftime Report Final Trades</a>,&#8221; Malcolm Ethridge of CIC Wealth Management named PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) <a href="https://www.benzinga.com/25/02/43942860/paypal-eyes-double-digit-eps-growth-by-2027-teams-up-with-verifone-jp-morgan-more">his final trade</a>.
On Feb. 25, PayPal issued an outlook ahead of its Investor Day event. The company reiterated guidance for an adjusted EPS growth of 6%-10% and transaction margin dollar growth, excluding the impact of interest on customer balances of growth of at least 5%. The company expects high single-digit transaction margin dollar growth and low teens+ adjusted EPS growth by 2027.
Kevin Simpson of Capital Wealth Planning said Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is his top pick out of the Mag 7 names, having great free cash flow and huge margins.
On Friday, Citizens Capital Markets analyst Andrew Boone reiterated Meta Platforms with a Market Outperform rating and maintained a $750 price target.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jim Lebenthal of Cerity Partners said AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is a stock in a nice uptrend. It has pulled back a little bit. It has a very attractive valuation, good management and good product pipelines, he added.
AbbVie released on March 15 the final analysis of the confirmatory Phase 3 MIRASOL trial of Elahere (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy.
Stephanie Link picked Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), down 23% from its highs.
As per the recent news, Snowflake, on March 6, appointed Mike Gannon as chief revenue officer.
Price Action:
<ul>
<li>PayPal shares dipped 5.4% to close at $65.15 on Friday.</li>
<li>Meta shares fell 4.3% to close at $576.74 during Friday's session.</li>
<li>AbbVie shares gained 1.3% to close at $205.29 on Friday.</li>
<li>Snowflake shares dipped 4.1% to settle at $150.63.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44534977/jim-cramer-healthpeak-properties-is-a-reasonable-reit-recommends-buying-this-health-care-stock">Jim Cramer: Healthpeak Properties Is A &#8216;Reasonable&#8217; REIT, Recommends Buying This Health Care Stock</a></li>
</ul>
Photo: Shutterstock

Media

ABBV

PYPL

SNOW

Meta, Snowflake, PayPal And Health Care Stock On CNBC's 'Final Trades'

From Combine to Global Stages, the NFL&#8217;s Growth is Advertising Gold 
Despite today's fractured media market, the NFL continues to expand an already massive audience. Advertisers eagerly poured <a href="https://www.foxbusiness.com/lifestyle/superbowl-lviii-ads-to-cost-7-million-per-30-second-slot">$650 million</a> into ads for Super Bowl LVIII in 2024, which returned multiples as consumers spent <a href="https://nrf.com/research-insights/holiday-data-and-trends/super-bowl">$18.6 billion</a> on food, drinks, merchandise, and entertainment to enjoy the big game in 2025. Advertising appetite for this year's Super Bowl LIX broke new records with <a href="https://www.foxcorporation.com/news/business/2025/super-bowl-lix-on-fox-and-tubi-generates-more-than-800-million-in-gross-advertising-revenue/#:~:text=">$800 million</a> in spending to reach a record-breaking 127.7 million viewers. More than a sport, the NFL is the gold standard for brand building at scale.&nbsp;
"It All Starts Here" at the NFL Combine
At the heart of the NFL's success is the teams' ability to replenish their ranks with elite talent. Each year, the NFL Combine serves as the epicenter of new beginnings. &#8220;It All Starts Here,&#8221; where aspiring rookies showcase their skills and personalities for a roster spot to chase their Super Bowl dreams. Once a scouting event for teams, agents, and media, the Combine in recent years doubles up as an opportunity for fans to watch the next generation of NFL stars under one roof. The 2025 Combine drew <a href="https://www.wishtv.com/sports/nfl-combine-experience-indianapolis-2025/#:~:text=Over%2030%2C000%20fans%20attend%20NFL%20Combine%20Experience%2C%20setting%20new%20record&amp;text=INDIANAPOLIS%20(WISH)%20%E2%80%94%20The%20NFL,18%2C000%20fans%20on%20Saturday%20alone">30,000 general public attendees</a> and <a href="https://sports.yahoo.com/article/nfl-network-sees-highest-scouting-184952171.html">484,000 viewers</a> for the Saturday workouts featuring quarterbacks, running backs, and wide receivers.
A Diverse Set of NFL Fans Flock to Indianapolis&nbsp;&nbsp;
The diverse crowd at the Combine reflects the NFL's unparalleled reach. Outside chilly Lucas Oil stadium, a cluster of attendees sought out the statue of iconic quarterback Peyton Manning, the first ever to win Super Bowls with two different teams. At dinner bar-side, a Giants fan and music lawyer from NYC, a Lions fan and mortgage broker from Detroit, and a Niners fan and tech marketer from San Jose discovered their mutual love of the game. In the hotel lobby, college students in Browns gear shared their aspirations for careers in sports journalism, videography, and business.
At the stadium, jersey-wearing families and friends of the aspiring rookies applauded a speedy 40-yard drill and cheered their favorite prospects. A child quipped "Cam is better than Shedeur" as the quarterbacks warmed up. Possibly the best illustration of the NFL's continued growth is a boy in rookie QB Bo Nix's jersey checking the front rows for the closest view of the incoming class – the newest crop of NFL aspirants and future ad stars pulling in the next generation of fans.
Fans Weigh in on the NFL's Appeal
Game days put pure athleticism on display from improbable <a href="https://x.com/NFL/status/1905398660848124366?t=F8ElDNFtDuWlaJ8rR5_1Kg&amp;s=19">escapes</a> to incredible <a href="https://www.youtube.com/watch?v=KHGBuktEZo8">catches</a> and momentum shifting <a href="https://www.youtube.com/watch?v=n9JEL6YO-iQ">sacks</a>. Outcomes feed into narratives around a player's personal journey, franchise rivalries, and dynasties on the rise or decline that prolong engagement into the off-season.
"The NFL resonates with so many people from so many backgrounds because it represents the best talent from around the world competing at the highest level in the sport," said Ryan Stone, Vice President of Mortgage Banking with CrossCountry Mortgage. "It resonates with everyone from grandma to my little baby Jake!" 
"The NFL stands above the rest because every game carries weight – just 17 chances to prove who you are," said Ryan Hensley, Host of the <a href="https://www.youtube.com/@RyanGHensley">Ryan G Hensley Show</a>. "The Super Bowl isn't just a title game – it's a national moment, unmatched by the NBA Finals or the World Series. Football unites cities, sparks rivalries, and demands accountability. It's about urgency, toughness, and heart."
Andy Ellis, a Partner at YL Ventures, has traveled for New England Patriots games. From his perspective, "The NFL has made the game more watchable, Fantasy Football lets folks play secondary games based on it, and streaming platforms now have alternate announcers, so that fans at different knowledge levels can connect with the game. Being one of the more violent sports certainly doesn't hurt."
Constant Engagement Fuels NFL Expansion
The NFL grows through constant engagement. TV contracts, prime-time games, and streaming platforms like Amazon and YouTube maximize reach. Social media and behind-the-scenes content like Hard Knocks engage fans outside of games. Madden games and Nickelodeon broadcasts invite younger fans into the tent. 
Expanding regular season games into Mexico, the UK, Ireland, Germany, Spain, and Australia broadens the fan base. More international games complement global programs like the NFL Academy and the International Player Pathway that diversify the talent pipeline, which deliver additional engagement sources and audiences.
Layer in Fantasy Football, legalized sports betting, and pop culture crossovers, and the league has become a cultural powerhouse that keeps advertisers and fans coming back for more.

Sports

The NFL Kicks Off A New Season For Brand Building

As of March 31, 2025, three stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Avista Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVA#NYSE">AVA</a>)</h3>
<ul>
<li>On March 28, Avista reached all-party, all issues settlement in Oregon general rate case. The company's stock gained around 3% over the past five days and has a <a href="https://www.benzinga.com/quote/AVA">52-week high of $41.01</a>.</li>
<li>RSI Value: 75.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>AVA Price Action: Shares of Avista gained 2.4% to close at $41.01 on Friday.</li>
<li>Edge Stock Ratings: 77.14 Momentum score with Value at 74.86.</li>
</ul>
<a href="https://www.benzinga.com/quote/CCU" target="_blank" rel="noreferrer noopener"></a>
<h3 class="wp-block-heading">CenterPoint Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>)</h3>
<ul>
<li>On March 20, Morgan Stanley analyst David Arcaro maintained CenterPoint Energy with an Equal-Weight rating and raised the price target from $32 to $34. The company's stock gained around 5% over the past month and <a href="https://www.benzinga.com/quote/CNP">has a 52-week high</a> of $36.40.</li>
<li>RSI Value: 73.3</li>
<li>CNP Price Action: Shares of CenterPoint Energy gained 1.6% to close at $36.25 on Friday.</li>
</ul>
<h3 class="wp-block-heading">National Fuel Gas Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NFG#NYSE">NFG</a>)</h3>
<ul>
<li>On March 13, JP Morgan analyst Zach Parham maintained National Fuel Gas with a Neutral and raised the price target from $77 to $81. The company's stock gained around 5% over the past month and has a <a href="https://www.benzinga.com/quote/NFG">52-week high </a>of $79.49.</li>
<li>RSI Value: 71.9</li>
<li>NFG Price Action: Shares of National Fuel Gas gained 0.2% to close at $78.80 on Friday. </li>
</ul>
Learn more about BZ Edge Rankings—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">click to see scores for other stocks in the sector and see how they compare.</a>
Read This Next:<a href="https://www.benzinga.com/25/03/44534977/jim-cramer-healthpeak-properties-is-a-reasonable-reit-recommends-buying-this-health-care-stock"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/03/44534977/jim-cramer-healthpeak-properties-is-a-reasonable-reit-recommends-buying-this-health-care-stock">Jim Cramer: Healthpeak Properties Is A &#8216;Reasonable&#8217; REIT, Recommends Buying This Health Care Stock</a></li>
</ul>

Short Ideas

Top 3 Utilities Stocks That May Implode In March

Tesla shares are trading lower after Stifel cut its price target on the stock from $474 to $455.

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) with a Buy and maintains $40 price target.

BMEA

HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $40 Price Target

Royal Caribbean Cruises shares are trading lower after Jefferies initiated coverage on the stock with a Hold rating.

Small Cap

Press Releases

Breakthrough Quantum Chip Promises to Bring Industrial-Scale Computing Sooner Than Expected

D-Wave Quantum to Participate in Upcoming Investor Events

Quantum Computing Stocks Tumble Amid Industry Skepticism

SkyWater's Commercially Fabricated Qubits Power D-Wave's Landmark Achievement in Quantum Supremacy

Beyond Classical: D-Wave First to Demonstrate Quantum Supremacy on Useful, Real-World Problem

D-Wave Reports Fourth Quarter and Year-End 2024 Results

D-Wave Introduces Quantum Blockchain Architecture, Featuring Enhanced Security and Efficiency over Classical Computing

D-Wave Highlights Quantum Optimization Customer Growth and Introduces Expanded Offering to Accelerate Adoption and Deployment

Japan Tobacco and D-Wave Announce Quantum Proof-of-Concept Outperforms Classical Results for LLM Training in Drug Discovery

In Production: Ford Otosan Deploys Vehicle Manufacturing Application Built with D-Wave Technology

CSE:SCPE

IONQ

MSFT

QNCCF

RGTI

SCPCF

SKYT

TSXV:QNC

Agilysys

C3.ai

Alkami Technology

Alarm.com Holdings

AvePoint

BlackLine

Blackbaud

Bitdeer Technologies Group - Ordinary Shares

Bitdeer Technologies

Cleanspark

Sprinklr

Diginex

DoubleVerify Holdings

EverCommerce

Five9

Jamf Holding

Life360

NextNav

Opera Limited - American Depositary Shares

Opera

PagerDuty

Pony AI Inc. - American Depositary Shares

Pony AI

LiveRamp Holdings

Riot Platforms

RingCentral

Tuya Inc. American Depositary Shares, each representing one Class A Ordinary Share

Comments

D-Wave Quantum

뉴스

파트너 / 기고자

벤징가 글로벌